oxazoles has been researched along with Experimental Hepatoma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Q; Feng, S; Li, J; Pan, G; Wu, Z; Yang, W; Zhang, T | 1 |
| Abe, R; Fujise, Y; Murawaki, Y; Nagahara, T; Okano, J | 1 |
| Chang-De, J; Damdinsuren, B; Dono, K; Kobayashi, S; Kondo, M; Matsuura, N; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Sekimoto, M; Sugita, Y; Umeshita, K; Wakasa, K; Yamamoto, H | 1 |
| Ahmad, F; Degerman, E; Fales, HM; James, P; Lindh, R; Manganiello, V; Resjö, S; Yang, JS | 1 |
| Aoki, T; Burt, ME; Denton, JE; Faderan, MA; Lui, MS; Prajda, N; Reardon, MA; Sebolt, J; Weber, G; Zhen, YS | 1 |
| Elliott, WL; Faderan, MA; Liepnieks, JJ; Lui, MS; Natsumeda, Y; Weber, G | 1 |
| Alonso, MT; Leyland-Jones, B; O'Dwyer, PJ | 1 |
| Lui, MS; Weber, G; Zhen, YS | 1 |
| Keppler, DO; Leube, K | 1 |
| Aoki, T; Denton, JE; Lui, MS; Sebolt, J; Weber, G | 1 |
| Aoki, T; Sebolt, J; Weber, G | 1 |
| Kizaki, H; Lui, MS; Weber, G | 1 |
| Aoki, T; Chimoto, T; Hosokawa, S; Sagami, F; Sato, G; Sumigama, S; Tsukidate, K | 1 |
| Prajda, N | 1 |
| Ikegami, T; Natsumeda, Y; Weber, G | 1 |
| Achleitner, E; Lui, MS; Weber, G | 1 |
16 other study(ies) available for oxazoles and Experimental Hepatoma
| Article | Year |
|---|---|
Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway.
Topics: Animals; Apoptosis; Chenodeoxycholic Acid; Liver Neoplasms, Experimental; Mice; Oxazoles; Phosphatidylinositol 3-Kinases; Receptors, Cytoplasmic and Nuclear; Signal Transduction | 2022 |
Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.
Topics: Animals; Apoptosis; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Chemoprevention; Cyclooxygenase 2 Inhibitors; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Glutathione Transferase; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Male; Oxazoles; Oxidative Stress; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Time Factors | 2010 |
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
Topics: Actins; Animals; Benzenesulfonates; Body Weight; Choline Deficiency; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Damage; Genes, myc; Isoenzymes; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Male; Oxazoles; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar | 2003 |
Multisite phosphorylation of adipocyte and hepatocyte phosphodiesterase 3B.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipocytes; Amino Acid Sequence; Animals; Cells, Cultured; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Activation; Gene Expression; Hepatocytes; Insulin; Lipolysis; Liver Neoplasms, Experimental; Male; Marine Toxins; Mice; Molecular Sequence Data; Oxazoles; Phosphorylation; Protein Transport; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Subcellular Fractions | 2007 |
Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
Topics: Animals; Antimetabolites, Antineoplastic; Cells, Cultured; Dactinomycin; Deoxyribonucleotides; Glutamine; Humans; Isoxazoles; Liver Neoplasms, Experimental; Oxazoles; Rats; Rats, Inbred Strains; Ribonucleotides; Sarcoma, Experimental | 1982 |
Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
Topics: Animals; Antineoplastic Agents; Cell Line; Dose-Response Relationship, Drug; IMP Dehydrogenase; Isoxazoles; Liver; Liver Neoplasms, Experimental; Nucleotides; Oxazoles; Pentosephosphates; Pentosyltransferases; Phosphoribosyl Pyrophosphate; Rats; Ribavirin; Ribonucleosides | 1984 |
Acivicin: a new glutamine antagonist in clinical trials.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glutamine; Half-Life; Humans; Isoxazoles; Kinetics; Leukemia, Experimental; Liver Neoplasms, Experimental; Macaca mulatta; Male; Mice; Neoplasms; Oxazoles; Purines; Pyrimidines; Sarcoma, Experimental | 1984 |
Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Dipyridamole; Isoxazoles; Kinetics; Liver Neoplasms, Experimental; Oxazoles; Rats; Ribonucleosides | 1983 |
Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
Topics: Animals; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Drug Interactions; Female; Galactosamine; In Vitro Techniques; Isoxazoles; Liver Neoplasms, Experimental; Oxazoles; Pyrimidine Nucleotides; Rats; Rats, Inbred Strains | 1983 |
Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
Topics: Amidophosphoribosyltransferase; Animals; Antimetabolites; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Carbon-Nitrogen Ligases; Isoxazoles; Ligases; Liver; Liver Neoplasms, Experimental; Male; Nucleotides; Oxazoles; Pentosyltransferases; Phenotype; Rats; Rats, Inbred ACI | 1982 |
In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
Topics: Adenosine Triphosphate; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); In Vitro Techniques; Isoxazoles; Kinetics; Ligases; Liver; Liver Neoplasms, Experimental; Magnesium; Male; Oxazoles; Rats; Rats, Inbred ACI | 1982 |
Biochemical pharmacology of acivicin in rat hepatoma cells.
Topics: Animals; Carbon-Nitrogen Ligases; Cell Line; Cell Survival; Cytidine; Deoxycytidine; Deoxyribonucleotides; Dose-Response Relationship, Drug; Drug Synergism; Glycine; Guanosine; Isoxazoles; Ligases; Liver; Liver Neoplasms, Experimental; Oxazoles; Rats; Ribonucleotides | 1982 |
Toxicological response of rats to a novel monoamine oxidase type-A inhibitor, (5R)-3-[2-((1S)-3-cyano-1-hydroxypropyl)benzothiazol-6-yl]-5- methoxymethyl-2-oxazolidinone (E2011), orally administered for 13 weeks.
Topics: Administration, Oral; Animals; Benzothiazoles; Body Weight; Eating; Female; Glutathione S-Transferase pi; Glutathione Transferase; Harderian Gland; Hematologic Tests; Isoenzymes; Liver; Liver Neoplasms, Experimental; Male; Monoamine Oxidase Inhibitors; Organ Size; Oxazoles; Oxazolidinones; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Salivation; Thiazoles | 1999 |
Enzyme targets of antiglutamine agents in cancer chemotherapy.
Topics: Animals; Anthranilate Synthase; Antibiotics, Antineoplastic; Azaserine; Drug Synergism; Glutamine; Isoxazoles; Liver; Liver Neoplasms, Experimental; Nitrogenous Group Transferases; Oxazoles; Phosphoribosyl Pyrophosphate; Rats; Ribonucleotides; Transferases | 1985 |
Recovery of the activities of IMP dehydrogenase and GMP synthase after treatment with tiazofurin and acivicin in hepatoma cells in vitro.
Topics: Animals; Carbon-Nitrogen Ligases; Cycloheximide; Drug Interactions; IMP Dehydrogenase; Isoxazoles; Ketone Oxidoreductases; Ligases; Liver Neoplasms, Experimental; Oxazoles; Ribavirin; Ribonucleosides; Time Factors; Tumor Cells, Cultured | 1989 |
Inactivation by acivicin of rat brain CTP and GMP synthetases and depression of CTP and GTP concentrations.
Topics: Animals; Antibiotics, Antineoplastic; Brain; Carbon-Nitrogen Ligases; Cell Line; Cytidine Triphosphate; Guanosine Triphosphate; Isoxazoles; Ligases; Liver; Liver Neoplasms, Experimental; Male; Oxazoles; Rats; Rats, Inbred ACI | 1985 |